Davide Leone & Partners Investment CO Ltd. Surface Oncology, Inc. Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $1.73 Million - $2.44 Million	-268,960 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $564,282 - $1.08 Million	77,832 Added 40.72%	268,960 $2.1 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $1.31 Million - $2 Million	191,128 New	191,128 $1.77 Million

Others Institutions Holding SURF

# of Institutions

Shares Held

315K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

171K
Shares

$0
0.24% of portfolio
Kingsbury Capital Investment Advisors LLC Evanston, IL

144K
Shares

$0
0.23% of portfolio

View Full List

About Surface Oncology, Inc.

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

More about SURF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account